Delivery Order SPE2DB24D2012-SPE2DB24FBVGQ

Award Date 7/16/24
Potential Completion Date 7/17/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,495.45, is for the delivery of calcium gluconate 1,000 mg/10 ml vials. The contract has a firm fixed price pricing type and an ultimate completion date of December 2, 2024. This contract is not associated with a set-aside requirement. AmerisourceBergen Drug Corp is the prime contractor, and...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4563850638 - Calcium Gluconate 10,000 mg/100 ml, 100 ml. The contract has a ceiling value of $4,801.45 and a period of performance through March 5, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 5,000 mg/50 ml vials of calcium gluconate, a medical product used in various treatments. The contract is a Delivery Order valued at $1,322.70 with a firm fixed price pricing type. It has an ultimate completion date of February 4, 2025. The contract is not designated as a set-aside....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,146.95, is for the delivery of calcium gluconate 1,000 mg/10 ml vials. The contract is a firm fixed-price delivery order with a completion date of January 8, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp, the prime...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $6,206.90, is for the delivery of calcium gluconate 1,000 mg/10 mL vials. This is a firm fixed-price delivery order contract with an ultimate completion date of January 13, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,022.72 firm fixed-price delivery order covers the supply of 4567049965 - Calcium Gluconate 1,000 mg/10 mL vials, with a performance period through January 28, 2025. The contract is not designated as a set-aside procurement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,855.59, is for the delivery of Calcium Gluconate 1,000 mg/10 ml vials. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,670.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The contract is for the delivery of 4567402272 - Calcium Gluconate 10,000 mg/100 mL, 100 mL, a critical pharmaceutical...
This federal contract award, valued at $1,673.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Calcium Gluconate Injection, 1,000 mg/10 mL, with a completion date of April 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical to provide a comprehensive range of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the supply of calcium gluconate injection medication, valued at $2,334.80 with a completion date of March 11, 2024. The award does not have a set-aside designation. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of...
  • SPE2DB24D2012
    Indefinite Delivery Contract
  • SPE2DB24D2012-SPE2DB24FBVGQ
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,092.44, is for the delivery of 4565164171 - Calcium Gluconate 1,000 mg/10 ml Vials, 10 ml. The contract is a Firm Fixed Price (FFP) arrangement with a completion date of July 17, 2024. This appears to be a supplemental or individual delivery order against a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. There is no indication that this specific delivery order or the overall IDC have a set-aside designation, suggesting open competition.

Generated 5/17/25, 10:06 AM